Changchun BCHT Biotechnology Co. (SHA:688276)
China · Delayed Price · Currency is CNY 18.71
+3.12 (20.01%)
Aug 20, 2026, 3:00 PM CST
SHA:688276 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 19, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 7,740 | 7,802 | 10,387 | 22,628 | 28,531 | 28,321 | |
Market Cap Growth | -25.93% | -24.89% | -54.10% | -20.69% | 0.74% | - |
Enterprise Value | 7,863 | 7,919 | 10,172 | 22,168 | 27,501 | 27,236 |
Last Close Price | 18.71 | 18.86 | 24.91 | 54.15 | 68.11 | 67.49 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 19, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | - | 44.75 | 45.16 | 157.17 | 116.28 |
Forward PE | - | 11.12 | 13.55 | 32.89 | 55.21 | 44.22 |
PS Ratio | 13.11 | 12.89 | 8.45 | 12.40 | 26.63 | 23.56 |
PB Ratio | 2.01 | 2.03 | 2.46 | 5.63 | 8.02 | 8.29 |
P/TBV Ratio | 2.19 | 2.21 | 2.67 | 6.16 | 8.50 | 8.87 |
P/OCF Ratio | 24.28 | 33.74 | 25.55 | 88.67 | 716.54 | 201.86 |
PEG Ratio | - | 0.52 | 0.59 | - | - | - |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 19, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 13.32 | 13.09 | 8.28 | 12.15 | 25.67 | 22.66 |
EV/EBITDA Ratio | - | - | 28.66 | 34.97 | 119.12 | 88.50 |
EV/EBIT Ratio | - | - | 40.57 | 40.90 | 171.96 | 113.75 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 19, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.09 | 0.07 | 0.02 | 0.01 | - | - |
Debt / EBITDA Ratio | - | - | 0.29 | 0.03 | - | - |
Net Debt / Equity Ratio | 0.03 | 0.02 | -0.06 | -0.10 | -0.24 | -0.34 |
Net Debt / EBITDA Ratio | -0.75 | -0.36 | -0.68 | -0.66 | -3.75 | -3.75 |
Net Debt / FCF Ratio | -1.36 | -0.36 | 1.78 | 1.96 | 3.45 | 2.35 |
Asset Turnover | 0.11 | 0.12 | 0.24 | 0.39 | 0.25 | 0.36 |
Inventory Turnover | 0.90 | 1.07 | 1.11 | 1.08 | 0.84 | 1.18 |
Quick Ratio | 0.99 | 1.03 | 1.91 | 1.98 | 2.56 | 2.56 |
Current Ratio | 1.28 | 1.29 | 2.14 | 2.21 | 2.87 | 2.93 |
Return on Equity (ROE) | -6.63% | -6.51% | 5.63% | 13.22% | 5.20% | 9.37% |
Return on Assets (ROA) | -3.60% | -3.74% | 3.06% | 7.26% | 2.36% | 4.51% |
Return on Invested Capital (ROIC) | -7.66% | -7.78% | 6.01% | 15.31% | 5.93% | 11.95% |
Return on Capital Employed (ROCE) | -7.60% | -7.70% | 5.80% | 13.40% | 4.50% | 7.00% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 19, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | -3.45% | -3.37% | 2.23% | 2.21% | 0.64% | 0.86% |
FCF Yield | -1.16% | -2.25% | -1.31% | -0.95% | -0.88% | -1.74% |
Dividend Yield | 0.90% | - | 0.68% | 0.28% | 0.22% | 0.15% |
Payout Ratio | - | - | 27.74% | 12.50% | 22.74% | - |
Buyback Yield / Dilution | - | 1.01% | -0.10% | -0.36% | -5.03% | -7.07% |
Total Shareholder Return | 0.90% | 1.01% | 0.58% | -0.08% | -4.81% | -6.93% |